Life Sciences / Oncolytic Virus Therapy Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma
Oncolytic Virus Therapy Market - Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma
Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Oncolytic Virus Therapy Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of around 25.09% during the review period (2022 to 2027).
Oncolytic Virus Therapy Market Overview
The global oncolytic virus immunotherapy market holds huge growth potential, and multiple clinical studies are underway with over 35 companies operating in this space.
However, 90% of these oncolytic drug candidates are in the late stage of discovery or in preclinical phase, where there is great uncertainty around the success of these molecules to reach the clinical phase and launch a new drug molecule. Failure of these molecules in late stage of clinical developments may be leveling off for companies operating in the oncolytic virus immunotherapy market.
However, there exists an error between industry sponsored and independently run clinical trials for oncolytic virus immunotherapy, which is expected to delay the availability of these drugs in the global market. Thus, the increasing clinical research on oncolytic virus is projected to boost the growth of the oncolytic virus immunotherapy market.
Industry News:
FDA Approves IMLYGIC™ (Talimogene Laherparepvec) As First Oncolytic Viral Therapy In The US
Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for IMLYGIC™ (talimogene laherparepvec), a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous and nodal lesions in patients with melanoma recurrent after initial surgery. IMLYGIC has not been shown to improve overall survival or have an effect on visceral metastases. IMLYGIC is the first oncolytic viral therapy approved by the FDA based on therapeutic benefit demonstrated in a pivotal study.1-3
What are the major Applications, Types and Regions for Oncolytic Virus TherapyMarket?
North America is estimated to be the prominent region for the global oncolytic virus immunotherapy market in 2019, and is expected to grow at a significant CAGR over the predefined timeframe, owing to high prevalence of cancer, specifically melanoma cancer in the region.
In addition, strong presence of leading manufacturers and high rate of manufacturer’s sponsorship are contributing to greater availability of oncolytic virus immunotherapy in the region. Growth prospects of the oncolytic virus immunotherapy market are also expected to be high in Europe.
All these factors greatly affect the Oncolytic Virus Therapy Market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Oncolytic Virus Therapy Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Oncolytic Virus Therapy Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Oncolytic Virus Therapy Market report scope?
Report Attributes
Report Details
Forecast Period 2022 to 2028 CAGR
CAGR of 25.09 % during the review period (2022 to 2027).
Yes, the report can be customized as per your needs
Key Takeaways from this Healthcare IT Report
Evaluate Oncolytic Virus Therapy Market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
Analyze the sales and distribution channels across geographies to enhance top-line revenues.
Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the Oncolytic Virus Therapy Market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
Frequently Asked Questions
What is the study period of this market?
The Oncolytic Virus Therapy Market is studied from 2017 - 2027.
What is the growth rate of Oncolytic Virus Therapy Market?
The Oncolytic Virus Therapy Market is growing at a CAGR of 25.09% over the next 5 years.
Who are the key players in Oncolytic Virus Therapy Market?
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
